#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Evaluation of four commercial tests for detecting ceftiofur in waste milk bulk tank samples


Autoři: Marlene Belmar aff001;  Sharif Aly aff002;  Betsy M. Karle aff003;  Richard V. Pereira aff001
Působiště autorů: Department of Population Health and Reproduction, School of Veterinary Medicine, University of California Davis, Davis, CA, United States of America aff001;  Veterinary Medicine Teaching and Research Center, School of Veterinary Medicine, University of California Davis, Tulare, CA, United States of America aff002;  Cooperative Extension, Division of Agriculture and Natural Resources, University of California, Orland, CA, United States of America aff003
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pone.0224884

Souhrn

The objective of this study was to identify factors affecting the accuracy of four commercial tests for ceftiofur drug residue in milk samples from bulk tank waste milk (WM). WM samples were collected from 12 California dairy farms which were initially tested using liquid chromatography (LC-MS/MS) to confirm their negative status for drug residues above the FDA established tolerance/safe levels. The milk samples were also tested for fat, protein, lactose, solids non-fat (SNF), somatic cell count (SCC), coliform count, and standard plate count (SPC). Each WM sample was divided into two aliquots, one labeled as negative for drug residues (WMN) and the second spiked with ceftiofur as positive for ceftiofur residues (WMPos). Both types of WM samples were tested to evaluate the performance of 4 commercially available tests: Penzyme® Milk Test, SNAP® β–lactam, BetaStar® Plus and Delvo SP-NT®. Three assays in triplicates for the WMN and WMPos were conducted for each WM sample. Test were evaluated using sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio. Kruskal-Wallis method was used to evaluate the effect of milk quality parameters on true positive (TP) and false negative (FN) test results. All WMPos samples were identified as positive by all four tests, rendering 100% sensitivity for each test. The specificity for Penzyme, BetaStar, Delvo, and SNAP tests were 59.2, 55.5, 44.4, and 29.6, respectively. Overall, all tests correctly identified samples with ceftiofur residues (WMPos), as shown by 100% sensitivity. Greater variability was observed regarding identification of samples free of any drug residue, with Penzyme and BetaStar having the highest risk for correctly identifying TN samples. Our findings indicate that when selecting commercial tests to detect drug residues in WM, milk quality parameters must be considered if the aim is to reduce FP test results.

Klíčová slova:

Drug therapy – Antimicrobials – Fats – Milk – Enzyme assays – Antimicrobial resistance – Drug screening – Lactose


Zdroje

1. Dunne EF, Fey PD, Kludt P, Reporter R, Mostashari F, Shillam P, et al. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA: the journal of the American Medical Association. 2000;284(24):3151–6.

2. Collignon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM. World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2009;49(1):132–41. doi: 10.1086/599374 19489713

3. USDA. Dairy Cattle Management Practices in the United States, 2014. Fort Collins, CO. 2016.

4. Love WJ, Lehenbauer TW, Karle BM, Hulbert LE, Anderson RJ, Van Eenennaam AL, et al. Survey of management practices related to bovine respiratory disease in preweaned calves on California dairies. J Dairy Sci. 2016;99(2):1483–94. Epub 2015/12/29. doi: 10.3168/jds.2015-9394 26709177.

5. Pereira RV, Siler JD, Bicalho RC, Warnick LD. Multiresidue screening of milk withheld for sale at dairy farms in central New York State. Journal of dairy science. 2014. doi: 10.3168/jds.2013-7421 24440252

6. Tempini PN, Aly SS, Karle BM, Pereira RV. Multidrug residues and antimicrobial resistance patterns in waste milk from dairy farms in Central California. Journal of Dairy Science. 2018. https://doi.org/10.3168/jds.2018-14398.

7. Pereira RV, Siler JD, Bicalho RC, Warnick LD. In Vivo Selection of Resistant E. coli after Ingestion of Milk with Added Drug Residues. PloS one. 2014;9(12):e115223. doi: 10.1371/journal.pone.0115223 25506918

8. Navratilova P, Veterinarni a Farmaceuticka Univ., Brno (Czech Republic). Ustav Hygieny a Technologie Mleka. Screening methods used for the detection of veterinary drug residues in raw cow milk—a review. 2008;v. 26.

9. FDA. Beta Lactam and other test methods for use under appendix N and section 6 of the Grade “A” Pasteurized Milk Ordinance (PMO). 2016.

10. Gibbons-Burgener SN, Kaneene JB, Lloyd JW, Leykam JF, Erskine RJ. Reliability of three bulk-tank antimicrobial residue detection assays used to test individual milk samples from cows with mild clinical mastitis. Am J Vet Res. 2001;62(11):1716–20. 11703013.

11. Andrew SM. Effect of fat and protein content of milk from individual cows on the specificity rates of antibiotic residue screening tests. Journal of dairy science. 2000;83(12):2992–7. doi: 10.3168/jds.S0022-0302(00)75200-3 11132872

12. CFR PART 556—Tolerance for residues of new animal drugs in food, (2017).

13. Neogen. Penzyme Milk Test [cited 2019]. Available from: foodsafety.neogen.com/pdf/prodinfo/pmilk.pdf.

14. FDA. M-a-85 (Revision #14) Beta Lactam And Other Test Methods For Use Under Appendix N And Section 6 Of The Grade “A” Pasteurized Milk Ordinance (PMO). 2012.

15. FDA. M-a-85 (Revision #16) Beta Lactam and Other Test Methods For Use Under Appendix N And Section 6 Of The Grade “A” Pasteurized Milk Ordinance (PMO). 2018.

16. Stead SL, Ashwin H, Richmond SF, Sharman M, Langeveld PC, Barendse JP, et al. Evaluation and validation according to international standards of the Delvotest® SP-NT screening assay for antimicrobial drugs in milk. International Dairy Journal. 2008;18(1):3–11. https://doi.org/10.1016/j.idairyj.2007.06.006.

17. FDA. M-I-18-9 Tolerance And/Or Target Testing Levels Of Animal Drug Residues In Milk 2018.

18. Dohoo IR, Martin SW, Stryhn H. Veterinary epidemiologic research. Charlottetown, P.E.I.: AVC Inc.; 2003.

19. Pereira RV, Lima S, Siler JD, Foditsch C, Warnick LD, Bicalho RC. Ingestion of Milk Containing Very Low Concentration of Antimicrobials: Longitudinal Effect on Fecal Microbiota Composition in Preweaned Calves. PLoS One. 2016;11(1):e0147525. doi: 10.1371/journal.pone.0147525 26808865; PubMed Central PMCID: PMC4726667.

20. EFSA Panel on Biological Hazards (BIOHAZ) RA, Allende A, Bolton D, Chemaly M, Davies R, Fernández Escámez PS, Girones R, Koutsoumanis K, Lindqvist R, Nørrung B, Robertson L, Ru G, Sanaa M, Simmons M, Skandamis P, Snary E, Speybroeck N, Kuile BT, Threlfall J, Wahlström H, Bengtsson B, Bouchard D, Randall L, Tenhagen B-A, Verdon E, l J, Brozzi R, Guerra B, Liebana E, Stella P and Herman L. Scientific Opinion on the risk for the development of Antimicrobial Resistance (AMR) due to feeding of calves with milk containing residues of antibiotics. EFSA Journal 2017. 2017;15(1). doi: 10.2903/j.efsa.2017.4665

21. Van Eenennaam AL, Cullor JS, Perani L, Gardner IA, Smith WL, Dellinger J, et al. Evaluation of milk antibiotic residue screening tests in cattle with naturally occurring clinical mastitis. J Dairy Sci. 1993;76(10):3041–53. doi: 10.3168/jds.S0022-0302(93)77644-4 8227629.

22. Carlsson A, Bjorck L, Persson K. Lactoferrin and lysozyme in milk during acute mastitis and their inhibitory effect in Delvotest P. J Dairy Sci. 1989;72(12):3166–75. doi: 10.3168/jds.S0022-0302(89)79475-3 2628440.

23. Kang JH, Jin JH, Kondo F. False-positive outcome and drug residue in milk samples over withdrawal times. J Dairy Sci. 2005;88(3):908–13. doi: 10.3168/jds.S0022-0302(05)72757-0 15738224.

24. Harmon RJ, Schanbacher FL, Ferguson LC, Smith KL. Concentration of lactoferrin in milk of normal lactating cows and changes occurring during mastitis. Am J Vet Res. 1975;36(7):1001–7. 1096690.

25. CDFA CDoFaA. California Dairy Statistics Annual 2017 Data 2017.

26. Andrew SM. Effect of fat and protein content of milk from individual cows on the specificity rates of antibiotic residue screening tests. J Dairy Sci. 2000;83(12):2992–7. doi: 10.3168/jds.S0022-0302(00)75200-3 11132872.

27. Andrew SM. Effect of composition of colostrum and transition milk from Holstein heifers on specificity rates of antibiotic residue tests. J Dairy Sci. 2001;84(1):100–6. doi: 10.3168/jds.S0022-0302(01)74457-8 11210020.

28. Reybroeck W, Ooghe S, De Brabander HF, Daeseleire E. Validation of the betaeta-s.t.a.r. 1 + 1 for rapid screening of residues of beta-lactam antibiotics in milk. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010;27(8):1084–95. doi: 10.1080/19440041003724871 20512709; PubMed Central PMCID: PMC3471315.

29. Hillerton JE, Halley BI, Neaves P, Rose MD. Detection of antimicrobial substances in individual cow and quarter milk samples using Delvotest microbial inhibitor tests. J Dairy Sci. 1999;82(4):704–11. doi: 10.3168/jds.s0022-0302(99)75287-2 10212456.

30. FDA. TITLE 21—FOOD AND DRUGS, SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS. PART 573 FOOD ADDITIVES PERMITTED IN FEED AND DRINKING WATER OF ANIMALS. Subpart B—Food Additive Listing.

31. U.S. FDA. Grade “A” Pasteurized Milk Ordinance, (2017).

32. 2002/657/EC: Commission Decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results (Text with EEA relevance) (notified under document number C(2002) 3044), (2002).

33. Durel L, Gallina G, Pellet T. Assessment of ceftiofur residues in cow milk using commercial screening test kits. Vet Rec Open. 2019;6(1):e000329. Epub 2019/06/18. doi: 10.1136/vetreco-2018-000329 31205727; PubMed Central PMCID: PMC6541105.


Článok vyšiel v časopise

PLOS One


2019 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#